EMEA-001204-PIP01-11

Key facts

Active substance
  • Ezetimibe
  • Atorvastatin calcium
Therapeutic area
Cardiovascular diseases
Decision number
P/0018/2012
PIP number
EMEA-001204-PIP01-11
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
  • Treatment of hypercholesterolaemia
  • Treatment of mixed hyperlipidaemia
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.

Tel. +33 180464738
E-mail: pip.information@merck.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating